These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 21454209
1. The bone marrow niche in Waldenström's macroglobulinemia. Ghobrial IM, Zhang Y, Liu Y, Ngo H, Azab F, Sacco A, Azab A, Maiso P, Morgan B, Quang P, Issa G, Roccaro A. Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):118-20. PubMed ID: 21454209 [Abstract] [Full Text] [Related]
2. The bone marrow microenvironment in Waldenström macroglobulinemia. Agarwal A, Ghobrial IM. Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):218-21. PubMed ID: 23490994 [Abstract] [Full Text] [Related]
3. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia. Jalali S, Ansell SM. Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460 [Abstract] [Full Text] [Related]
4. Targeting the bone marrow in Waldenstrom macroglobulinemia. Ghobrial IM, Zhang Y, Liu Y, Ngo H, Azab F, Sacco A, Azab A, Maiso P, Morgan B, Quang P, Issa GC, Leleu X, Roccaro AM. Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S65-9. PubMed ID: 22035751 [Abstract] [Full Text] [Related]
5. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia. Muz B, de la Puente P, Azab F, Ghobrial IM, Azab AK. Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031 [Abstract] [Full Text] [Related]
6. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia. Jalali S, Ansell SM. Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017 [Abstract] [Full Text] [Related]
7. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma. Jondeau K, Alterescu R, Franc B, Davi F, Massé JM, Boukour S, Le Parc JM, Cramer EM. Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885 [Abstract] [Full Text] [Related]
8. Angiogenesis in Waldenström's macroglobulinemia. Terpos E, Tasidou A, Kastritis E, Eleftherakis-Papaiakovou E, Gavriatopoulou M, Migkou M, Dimopoulos MA. Clin Lymphoma Myeloma; 2009 Mar; 9(1):46-9. PubMed ID: 19362971 [Abstract] [Full Text] [Related]
10. Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia. Azab F, Azab AK, Maiso P, Calimeri T, Flores L, Liu Y, Quang P, Roccaro AM, Sacco A, Ngo HT, Zhang Y, Morgan BL, Carrasco RD, Ghobrial IM. Clin Cancer Res; 2012 Jan 01; 18(1):91-104. PubMed ID: 22010211 [Abstract] [Full Text] [Related]
14. Occurrence of acute monocytic leukemia in a case of untreated Waldenström's macroglobulinemia. Murashige N, Tabanda R, Zalusky R. Am J Hematol; 2002 Oct 01; 71(2):94-7. PubMed ID: 12353307 [Abstract] [Full Text] [Related]
16. Macroglobulinemia and chronic B-cell type lymphocytic leukemia in japan--study of autopsy cases. Kikuchi M, Mitsui T, Takeshita M, Okamura H. Jpn J Clin Oncol; 1983 Sep 01; 13(3):607-22. PubMed ID: 6417377 [Abstract] [Full Text] [Related]
17. Waldenstrom's macroglobulinaemia--a case report. Chin NS, Teh A, Lee MK. Med J Malaysia; 1989 Jun 01; 44(2):167-70. PubMed ID: 2516603 [Abstract] [Full Text] [Related]
18. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases. Andriko JA, Aguilera NS, Chu WS, Nandedkar MA, Cotelingam JD. Cancer; 1997 Nov 15; 80(10):1926-35. PubMed ID: 9366295 [Abstract] [Full Text] [Related]
19. Anti-angiogenic therapies in the treatment of Waldenstrom's Macroglobulinemia. Sacco A, Ghobrial IM, Roccaro AM. Curr Cancer Drug Targets; 2011 Nov 15; 11(9):1025-9. PubMed ID: 21933107 [Abstract] [Full Text] [Related]